• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.48% Nasdaq Up 0.28%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    2.43 Down 0.05(2.02%) Jan 20, 4:00PM EST
    Prev Close:2.48
    Open:2.48
    Bid:1.80 x 800
    Ask:2.62 x 200
    1y Target Est:4.57
    Beta:2.09017
    Next Earnings Date: 3-Feb-17IMGN Earnings announcement
    Day's Range:2.37 - 2.48
    52wk Range:1.51 - 10.08
    Volume:1,295,291
    Avg Vol (3m):2,039,530
    Market Cap:212.14M
    P/E (ttm):N/A
    EPS (ttm):-1.79
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMGN

    Comparison

    Symbol% ChgMkt Cap
    IMGNDown 2.02%212.14M
    SGENDown 0.81%8.32B
    PFEUp 0.22%192.79B
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.10
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-17) :-1.67
    Quarterly EPS Est (Dec-16) :-0.38
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback